Effective for dates of service on or after November 1, 2020, segesterone acetate and ethinyl estradiol vaginal system (Annovera®) is added as a benefit under Family Planning, Access, Care and Treatment (Family PACT) and Medi-Cal programs for clinic dispensing, and for Family PACT pharmacy dispensing.
For clinic dispensing, HCPCS code J7303 (contraceptive supply, hormone containing vaginal ring, each) must be billed with modifier U1 for etonogestrel and ethinyl estradiol (NuvaRing®) or U2 for segesterone acetate and ethinyl estradiol vaginal system (Annovera).
HCPCS code J7303U1 is restricted to a dispensing quantity of up to 13 rings, per client, with a maximum of two dispensings in a 12-month period. HCPCS code J7303U2 is restricted to one ring per dispensing, per client, with a maximum of two dispensings in a 12-month period. For both codes, a Treatment Authorization Request (TAR) is required for a third dispensing of the same product requested within a 12-month period.
Pharmacy dispensing of segesterone acetate and ethinyl estradiol vaginal system (Annovera) has the same restrictions as noted for J7303U2.